TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02766478

Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“Enrollment and study activities were suspended due to COVID-19.”

The sponsor’s own words in the registry.

Life of this trial

20162017201820192020202120222023Registered2016-05-06Started2017-10-16Stopped2021-07-23Results posted2022-09-27

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Emory University
Sponsor type
University, hospital or other
Conditions
Prostate Cancer
Interventions
Genistein; Placebo
Participants
10
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.